/Images/649c44339b81d5725fcd95da_ted-dinan.jpg?width=900&height=900&name=649c44339b81d5725fcd95da_ted-dinan.jpg "649c44339b81d5725fcd95da_ted-dinan")
Professor Ted Dinan
Medical Director
Professor Ted Dinan is the Medical Director at Atlantia Clinical Trials. He is an Emeritus Professor of Psychiatry and a Principal Investigator in the Alimentary Pharmabiotic Centre at University College Cork (UCC). He was also the founding member at APC Microbiome Ireland, a leading research center focused on the role of the gut microbiota in health and stress-related disorders.
Prof. Dinan has held prestigious academic positions, including Chair of Clinical Neurosciences and Professor of Psychological Medicine at St. Bartholomew’s Hospital, London, and Senior Lecturer in Psychiatry at Trinity College Dublin.
His primary research interests encompass the gut-brain axis, particularly the influence of gut microbiota on stress-related disorders, and the regulation of the Hypothalamic-Pituitary-Adrenal (HPA) axis. In 2019, he was ranked by Expertscape as the number one global expert on microbiota and also listed in the Top 100 Global Makers and Mavericks. He has an h-index of 165.
Background & Credentials
Honors and Distinctions
- Recipient of the Kary Mullis Research Prize (2023)
- Ranked #1 Global Expert on Microbiota by Expertscape (2019)
- Listed in the Top 100 Global Makers and Mavericks (2019)
- Fellow of the Royal College of Physicians
- Fellow of the Royal College of Psychiatrists
- Fellow of the American College of Physicians
Expertise & Specialization
-
Gut-Brain Axis & Microbiome Research
-
Stress-Related Disorders
-
Hypothalamic-Pituitary-Adrenal (HPA) Axis Regulation
- Neuropharmacology
- Nutritional Psychiatry
- Clinical Neurosciences
Education & Training
- PhD in Pharmacology, University of London
- MD, National University of Ireland
- DSc, National University of Ireland
- MA in Psychology, New York
- LLB in Common Law
Experience
- Over 40 years of clinical experience
- Consultant Psychiatrist in London, Dublin, and Cork
Experience
Total Years of Experience: Over 40 years of clinical experience and working as a consultant Psychiatrist in London, Dublin, and Cork.
Career Journey: Prof. Dinan has an extensive career in psychiatry and neuroscience, with significant contributions to understanding the interplay between the gut microbiota and mental health. His work has been instrumental in establishing the field of psychobiotics, exploring how certain probiotics can influence brain function and behavior.
Key Contributions: Prof. Dinan has authored over 500 peer-reviewed articles and several books on neurobiology, pharmacology, and the gut-brain axis. He has pioneered research into the microbiome’s role in mental health, contributing to the development of psychobiotics. While having an advanced understanding of HPA axis dysregulation in stress and mood disorders.
Collaborations: Prof. Dinan serves on editorial boards of multiple international journals, including Human Psychopharmacology: Clinical and Experimental, Journal of Affective Disorders, and The Canadian Journal of Psychiatry. He collaborates with leading institutions and researchers globally in psychiatry, neuroscience, and microbiome research. Additionally, he plays an active role in guiding clinical research strategy at Atlantia, ensuring scientific rigor and translational relevance.
Role in the Company
As Medical Director at Atlantia Clinical Trials, Prof. Dinan provides scientific leadership and clinical oversight for trials investigating the impact of functional foods, probiotics, and nutritional interventions on health outcomes. His expertise ensures that Atlantia’s research programs are grounded in robust scientific methodology and aligned with the latest advancements in microbiome science. He is actively involved in the research design of all studies, data interpretation, and publication of the final manuscript.
Key Projects Worked On
Prof. Dinan has led over 100 studies on stress and related conditions and directed interventions using psychobiotics and other nutraceuticals. He has secured funding from major bodies including the EU, Wellcome Trust, and the Health Research Board.